Needham & Company LLC Reaffirms Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research note issued to investors on Thursday,Benzinga reports. They currently have a $80.00 price target on the stock. Needham & Company LLC’s price target would indicate a potential upside of 80.59% from […]
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research note issued to investors on Thursday,Benzinga reports. They currently have a $80.00 price target on the stock. Needham & Company LLC’s price target would indicate a potential upside of 80.59% from […]
